Impact Biomedical INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

AMEX
Impact BioMedical Inc.'s 2024 annual report highlights its IPO completion, intellectual property expansion, and ongoing development of its technology portfolio despite incurring a net loss.
AMEX
Impact BioMedical Inc. released its 2023 annual report, detailing its financial status, ongoing research, and strategic partnerships in the biotechnology sector.